Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.20739
Abstract: Interleukin (IL)‐23p19 and IL‐17 inhibitors have demonstrated high efficacy for psoriasis in randomized controlled trials, though real‐world data, particularly for risankizumab (IL‐23p19 inhibitor) and brodalumab (IL‐17 receptor (IL‐17R) inhibitor), is limited. read more here.
Keywords: drug survival; survival inhibitors; psoriasis british; versus biologics ... See more keywords
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2020 at "Stroke"
DOI: 10.1161/strokeaha.113.003453
Abstract: Atrial fibrillation (AF) is the most common type of arrhythmia in adults and becomes more common with increased age. Management of people with AF aims at preventing thromboembolic complications, and anticoagulant treatment with vitamin K… read more here.
Keywords: inhibitors versus; factor inhibitors; atrial fibrillation; factor ... See more keywords